Immunex Corp., of Seattle, Wash., has promoted Carrie McAninch toGenta Inc., of San Diego, Calif., has promoted Howard Sampson tovice president and chief financial officer.Microcide Pharmaceuticals, of Mountain View, Calif., has named JimRurka president and chief executive officer, and added Sydney Brennerof the Scripps Institute to its scientific advisory board.Sequana Therapeutics, Inc., of La Jolla, Calif., has appointed AudreyKeane as director of business development.Cytogen Corporation, of Princeton, N.J., has appointed RichardMurawski vice president, operations.Miles Biotechnology, of West Haven, Conn., has named MichaelJohnson director of strategic planning, and James Meade director oflicensing.VIMRx Pharmaceuticals Inc., of Stamford, Conn., announced theresignation of Richard Podell as its president and director. Areplacement has not yet been named.DNA Plant Technology Corp., of Cinnaminson, N.J., named RobertIgleheart as president of DNA's Freshword subsidiary and chiefoperating officer of DNAP.

(c) 1997 American Health Consultants. All rights reserved.